Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant

BACKGROUND: Paxlovid (nirmatrelvir/ritonavir) is a novel drug available under emergency use authorization by the Food and Drug Administration for the treatment of COVID-19 infection. Tacrolimus, a calcineurin inhibitor, is commonly used as an immunosuppressant medication in children with kidney tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Chelsea, Papiro, Talia, Greenberg, Jason H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388350/
https://www.ncbi.nlm.nih.gov/pubmed/35982345
http://dx.doi.org/10.1007/s00467-022-05712-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388350/
https://www.ncbi.nlm.nih.gov/pubmed/35982345
http://dx.doi.org/10.1007/s00467-022-05712-0

Ejemplares similares